28 Sep. 2000
New York, USA
Vicki Saporta, the Executive Director of the National Abortion Federation, speaks at a news conference called by Danco Labratories, in New York, September 28, 2000. The news conference followed the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone) the early option abortion pill for women. Danco Labratories has been granted exclusive liscense to manufacture, market and distribute Mifeprex in the United States.